Latest News

Update – Ocrelizumab for Primary Progressive MS in Canterbury

May 29, 2024 | Life with MS, News, Progressive, Treatments

On Wednesday 15 May, Multiple Sclerosis NZ raised how critical workforce shortages are impacting patients with Primary Progressive MS (PPMS) access to time sensitive disease modifying therapies. A business case prepared by clinical specialists had been under review for five […]


World MS Day 2024

May 27, 2024 | Life with MS, My Story, News

As a member of the MS International Federation (MSIF), MSNZ is proud to be involved with World MS Day which is officially marked on 30 May each year. World MS Day is a global awareness raising campaign for multiple sclerosis. Every year, the MS […]


Study: CFS biomarkers at the time of diagnosis may aid in MS prognosis

May 22, 2024 | News, Research, Study

Certain biomarkers in the cerebrospinal fluid (CSF) — the fluid surrounding the brain and spinal cord — around the time of a multiple sclerosis (MS) diagnosis may help predict the time to reaching certain disability milestones among people with a relapsing-remitting (RRMS) disease course, […]


Could a Simple Blood Test Predict MS

May 22, 2024 | News, Research, Study

In this article published by MS Australia, their research on antibodies shows promise that perhaps a simple blood test could predict MS one day. Using a large US biobank, blood from people with MS was screened before and after MS […]


Press Release: Access to Life-Changing MS Drug “snatched away” Due to Staff Shortages

May 15, 2024 | Advocacy, Funding, Life with MS, Media, News, Press Release, Treatments

A celebrated Pharmac decision late last year to fund a vital drug for many Multiple Sclerosis patients has fallen flat – with dozens being turned away for treatment due to severely stretched resources across a number of services. Multiple Sclerosis […]